ARDS — Aridis Pharmaceuticals Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.01m
- -$0.03m
- $3.09m
U.S. STOCKS ON THE MOVE-Pieris Pharma, Microsoft, Energy sector
U.S. STOCKS ON THE MOVE-Medtronic, Morgan Stanley, Bank of America
U.S. STOCKS ON THE MOVE-Teladoc Health, NVDIA, Chipotle
U.S. STOCKS ON THE MOVE-Pinterest, Sunrun, Tencent Music
Aridis Pharma up as European health agency agrees on study design for pneumonia drug
Brief: Aridis Pharmaceuticals Says Got Notice from Nasdaq On Stock Delisting
Brief: Aridis Receives Agreement From The European Medicines Agency On The Clinical Study Design And A Single Confirmatory Phase 3 Study Of AR-301
U.S. STOCKS ON THE MOVE-Liminal Biosciences, Tesla, Quad/Graphics
U.S. STOCKS ON THE MOVE-T2 Biosystems, GoodRx Holdings, ShiftPixy
Brief: Aridis’ AR-301 Monoclonal Antibody Receives FDA’S Qualified Infectious Diseases Product Designation
U.S. STOCKS ON THE MOVE-Domino's Pizza, Amazon, Salesforce
Aridis Pharma gains after FDA grants QIDP tag to pneumonia drug
Brief: Aridis Pharmaceuticals Files For Offering Up To 11.5 Million Shares Of Common Stock Together With Warrants To Purchase Up To 11.5 Million Common Shares
Brief: Aridis Pharmaceuticals' AR-301 Eligible For Consideration Under FDA’S Limited Population Pathway For Antibacterial And Antifungal Drugs
Brief: Aridis Pharmaceuticals Announces Q1 Results
U.S. STOCKS ON THE MOVE-Centerra Gold, gold miners, Travere Therapeutics
U.S. STOCKS ON THE MOVE-VerifyMe, Intel, Hewlett Packard Enterprise
Aridis Pharma gains after FDA nod to pneumonia drug study plan
U.S. STOCKS ON THE MOVE-Nvidia, Trevena, Akili